Biofrontera Inc.

NasdaqCM:BFRI Stock Report

Market Cap: US$12.9m

Biofrontera Balance Sheet Health

Financial Health criteria checks 3/6

Biofrontera has a total shareholder equity of $6.1M and total debt of $4.7M, which brings its debt-to-equity ratio to 77.7%. Its total assets and total liabilities are $24.8M and $18.7M respectively.

Key information

77.74%

Debt to equity ratio

US$4.72m

Debt

Interest coverage ration/a
CashUS$6.33m
EquityUS$6.07m
Total liabilitiesUS$18.72m
Total assetsUS$24.79m

Recent financial health updates

Recent updates

Analysis Article • Jan 23

There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise

Those holding Biofrontera Inc. ( NASDAQ:BFRI ) shares would be relieved that the share price has rebounded 42% in the...
Analysis Article • Oct 04

Benign Growth For Biofrontera Inc. (NASDAQ:BFRI) Underpins Its Share Price

You may think that with a price-to-sales (or "P/S") ratio of 0.3x Biofrontera Inc. ( NASDAQ:BFRI ) is definitely a...
User avatar
New Narrative • May 05

FDA Approval And Product Expansion Will Unlock New Markets

FDA approval for expanded Ameluz use and restructuring agreements enhance margins, supporting future revenue growth through increased average sales size and reduced costs.
Analysis Article • Feb 27

Investors Aren't Entirely Convinced By Biofrontera Inc.'s (NASDAQ:BFRI) Revenues

Biofrontera Inc.'s ( NASDAQ:BFRI ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a strong buy right...
Analysis Article • Sep 28

Biofrontera Inc.'s (NASDAQ:BFRI) Shares Leap 25% Yet They're Still Not Telling The Full Story

Biofrontera Inc. ( NASDAQ:BFRI ) shares have continued their recent momentum with a 25% gain in the last month alone...
Analysis Article • Aug 09

Further Upside For Biofrontera Inc. (NASDAQ:BFRI) Shares Could Introduce Price Risks After 40% Bounce

Those holding Biofrontera Inc. ( NASDAQ:BFRI ) shares would be relieved that the share price has rebounded 40% in the...
Analysis Article • May 24

Take Care Before Jumping Onto Biofrontera Inc. (NASDAQ:BFRI) Even Though It's 29% Cheaper

Biofrontera Inc. ( NASDAQ:BFRI ) shares have retraced a considerable 29% in the last month, reversing a fair amount of...
Analysis Article • Dec 30

Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%

Unfortunately for some shareholders, the Biofrontera Inc. ( NASDAQ:BFRI ) share price has dived 28% in the last thirty...

Financial Position Analysis

Short Term Liabilities: BFRI's short term assets ($13.2M) exceed its short term liabilities ($10.9M).

Long Term Liabilities: BFRI's short term assets ($13.2M) exceed its long term liabilities ($7.8M).

Debt to Equity History and Analysis

Debt Level: BFRI has more cash than its total debt.

Reducing Debt: BFRI's debt to equity ratio has increased from 0% to 77.7% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BFRI has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if BFRI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 08:21
End of Day Share Price 2026/07/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biofrontera Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Jonathan AschoffRoth Capital Partners